The Mycobacterium tuberculosis complex (MTBC) is the collective term given to the 3 group of bacteria that cause tuberculosis (TB) in mammals. It has been reported that 4 M. tuberculosis H37Rv, a standard reference MTBC strain, is attenuated in cattle compared to 5 Mycobacterium bovis. However, as M. tuberculosis H37Rv was isolated in the early 1930s, 6 and genetic variants are known to exist, we sought to revisit this question of attenuation of 7 M. tuberculosis for cattle by performing a bovine experimental infection with a recent 8 M. tuberculosis isolate. Here we report infection of cattle using M. bovis AF2122/97, 9 M. tuberculosis H37Rv, and M. tuberculosis BTB1558, the latter isolated in 2008 during a TB 10 surveillance project in Ethiopian cattle. We show that both M. tuberculosis strains caused 11 reduced gross and histopathology in cattle compared to M. bovis. Using M. tuberculosis 12 H37Rv and M. bovis AF2122/97 as the extremes in terms of infection outcome, we used 13 RNA-Seq analysis to explore differences in the peripheral response to infection as a route to 14 identify biomarkers of progressive disease in contrast to a more quiescent, latent infection. 15 Our work shows the attenuation of M. tuberculosis strains for cattle, and emphasizes the 16 potential of the bovine model as a 'One Health' approach to inform human TB biomarker 17 development and post-exposure vaccine development.
Introduction
The Mycobacterium tuberculosis complex (MTBC), the group of pathogens that 21 cause tuberculosis (TB) in mammals, show distinct host preference. Mycobacterium 22 tuberculosis is the hallmark member of the MTBC and the most deadly human pathogen 23 interaction have been described 21 . Much work remains in describing the precise host and 48 pathogen molecular factors involved in host preference 22 .
7 PPD-B stimulated whole blood supernatants were assayed for cytokine levels using a 150 custom-designed bovine Meso Scale Discovery ® (MSD) multiplex protein analysis platform 151 (Meso Scale Discovery ® , Gaithersburg, MD, USA). The bovine cytokines analysed were: IL-152 1β, IL-6, IL-10, IL-12, and TNF-α. Multiplex 96 well plates (supplied with target capture 153 antibodies spotted onto separate carbon electrodes in each well) were blocked with MSD ® 154 assay buffer for 30 min at room temperature before the addition of 25µl samples or MSD ® 155 standards (prepared according to manufacturer's instructions). Following 2h sample 156 incubation at room temperature, plates were washed and incubated for a further 2h with a Gross pathology and histopathology 165 Ten weeks after infection animals inoculated with M. tuberculosis were killed and 166 subjected to post-mortem analysis as indicated elsewhere 37 ; animals inoculated with M. bovis 167 were sacrificed six weeks after infection for post-mortem analysis as above. The presence of 168 gross pathological TB-like lesions was scored as previously described (37) . For histology, a 169 cross-sectional slice of the lymph node was collected into a 100 ml pot containing buffered 170 formalin. Collected tissue samples were shipped overnight from INRA to APHA Weybridge 171 for subsequent processing. 172 Tissues evaluated for gross pathology included the following lymph nodes: left and 173 right parotid, lateral retropharyngeal, medial retropharyngeal, submandibular, caudal, cranial 174 mediastinal and cranial tracheobronchial and pulmonary lymph nodes; lung tissue samples 175 were also taken. Tissue samples were preserved in 10% phosphate buffered formalin for 7 176 days before being embedded in paraffin wax. Four-micron sections were cut and stained with 177 hematoxylin and eosin (H&E); Ziehl-Neelsen staining was carried out for the detection of of each granuloma (I-IV) as well as assessing the quantity and location of AFB as previously 184 described 38, 39 . 185 8 186 Evaluation of tissue bacterial load 187 For bacteriology, up to 20 g of tissue was collected into 25 ml sterile containers and 188 frozen at -80 o C on the day of collection. Frozen tissues were shipped at +4 o C to APHA 189 Weybridge and immediately upon arrival were homogenised using a Seward Stomacher
190
Paddle Blender with bacterial enumeration undertaken as previously described 37 In previous work 13 we had seen that while stimulation of whole blood with the The presence of bacteria in the harvested tissue samples was investigated by semi-312 quantitative culture (Table 1) . It was possible to culture the respective infecting strain from at 313 least one organ from all experimental animals. However, the number of CFU/ml was usually 314 low for animals infected with either of the two M. tuberculosis strains, with zero bacterial 315 counts recorded in the lung or lung lymph nodes for all eight animals infected with either 316 strain of M. tuberculosis. Respiratory lymph nodes were mostly affected, with all 12 animals 317 having bacterial counts in this organ system (Table 1) . Granulomas were frequently multicentric, with several granulomas coalescing. 335 The number of granulomas of each stage in each tissue was variable ( Table 2 ). Most Figure 6C ). The change in expression of the genes within these pathways can be seen in 441 Figure 6D ; an overall downwards trend in genes encoding complement related factors was 442 found (e.g. C1Q1, C1QA, CFD and CFP) along with strong upregulation of TNF-signaling 443 related factors (e.g. TNF, NFKB2, TNFAIP3 and lymphotoxins alpha and beta LTA/LTB) 444 upon PPD-B stimulation of whole blood samples ( Figure 6D ). showed that bovine and human tubercle bacilli showed distinct virulence in animal models, 513 and in particular that the human bacillus was attenuated when used to infect cattle. Our work 514 has recapitulated these findings, using both the standard M. tuberculosis H37Rv strain as well BLK  BLNK  BTK  CD180  CD19  CD22  CD79A  CD79B  CLEC4A  CLEC6A  DAPP1  GRB2  IGHM  IRF7  ITPR3  LYN  PIK3CD  PLCD1  PLCG1  PLCG2  PTPN6  SYK  TICAM1  TLR8  TREM2  MMP3  MMP1  MMP12  THBS1  COL27A1   JAM3  CTSK  COL6A5  ITGB8  MMP14  CTSB  DMD  A2M  TNXB  SPP1 
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